
|Articles|October 1, 2004
Determine who has glaucoma and how to manage condition
New York-How do you determine whether a patient identified as having suspected glaucoma has glaucoma or will develop glaucoma? When should you treat a patient? How aggressive should treatment be?
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
Lotus submits NDA in South Korea for LENZ’s presbyopia treatment VIZZ
2
FDA approves Amneal Pharmaceuticals' cyclosporine ophthalmic emulsion 0.05%
3
Eydenzelt, Celltrion’s biosimilar referencing Eylea, approved in Canada
4
Belite Bio releases topline results from phase 3 DRAGON trial of Tinlarebant for STGD1
5

















































.png)


